Lanjie Xu , Yongliang Yu , Zhengwei Tan , Chunming Li , Qing Yang , Hongqi Yang , Xiaoyu Su , Yao Sun , Huizhen Liang

Institute of Chinese Herbal Medicine, He'nan Academy of Agricultural Sciences, Zhengzhou, 450002, Henan, China
Author    Correspondence author
Medicinal Plant Research, 2024, Vol. 14, No. 2   doi: 10.5376/mpr.2024.14.0006
Received: 08 Feb., 2024    Accepted: 12 Mar., 2024    Published: 25 Mar., 2024

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Xu L.J., Yu Y.L., Tan Z.W., Li C.M., Yang Q., Yang H.Q., Su X.Y., Sun Y., and Liang H.Z., 2024, Unveiling the genome of Chrysanthemum morifolium: adaptive evolution and medicinal value, Medicinal Plant Research, 14(2): 71-84 (doi: 10.5376/mpr.2024.14.0006)

This study provides a comprehensive analysis of the genomics of Chrysanthemum morifolium, covering its genetic linkage map construction, whole-genome assembly, and transcriptomics research findings. It highlights key genes and regulatory networks involved in Chrysanthemum morifolium development and the accumulation of medicinal components. The study explores the application value of genomics research in improving Chrysanthemum morifolium quality and commercial value. High-throughput sequencing technology has identified key genes controlling the biosynthesis of compounds such as flavonoids, which are crucial for enhancing the plant's medicinal activity. Functional molecular markers accelerate the process of targeted breeding. Research in whole-genome and comparative genomics has elucidated the cultivation and evolutionary history of Chrysanthemum morifolium. Genetic linkage maps have identified QTLs for inflorescence and leaf traits, promoting marker-assisted selection in breeding programs. Polyploidy and DNA methylation contribute to its adaptability and resilience. The study analyzes the regulatory mechanisms of Chrysanthemum morifolium's active medicinal components, such as flavonoids, phenolic acids, and terpenoids, and their roles in therapeutic effects. The study is expected to provide a road map for future research and applications in traditional medicine and modern healthcare, combining genomic data with traditional breeding techniques to accelerate the development of new varieties with strong disease resistance, broad adaptability, and high medicinal efficacy.

Chrysanthemum morifolium; Genomic research; Genetic map; Adaptive evolution; Medicinal value